Women’s Mental Health

Clinical Update 2024: Gabapentin (Neurontin) and Pregnancy

In this study with over 4000 infants exposed to gabapentin, the information is reassuring.  While we cannot rule out the possibility of a small increase in risk of cardiovascular malformations in gabapentin-exposed infants, gabapentin does not appear to be a major teratogen. 

By |2025-06-26T08:06:00-04:00October 23rd, 2024|Women's Mental Health|Comments Off on Clinical Update 2024: Gabapentin (Neurontin) and Pregnancy

Improving Cognitive Function After Surgical Menopause: A Randomized Controlled Trial of Lisdexamfetamine

The psychostimulant lisdexamfetamine was well-tolerated and improved both subjective and objective measures of attention and working memory in women undergoing surgical menopause.

By |2025-06-26T08:06:01-04:00October 16th, 2024|Women's Mental Health|Comments Off on Improving Cognitive Function After Surgical Menopause: A Randomized Controlled Trial of Lisdexamfetamine

Ketamine and Pregnancy: Taking a Look at the Practices of Ketamine Clinics

With ketamine and esketamine increasingly used to treat depression, especially in women of reproductive age, this study reveals important gaps in care, including inconsistencies in pregnancy testing, informed consent, and contraception practices among ketamine clinics in the United States. 

By |2025-06-26T08:06:02-04:00October 9th, 2024|Women's Mental Health|Comments Off on Ketamine and Pregnancy: Taking a Look at the Practices of Ketamine Clinics

Is it Safe for Breastfeeding Mothers to Use Benzodiazepines?

Clinically significant anxiety symptoms are common during the postpartum period and frequently complicate the treatment of postpartum depression.  While SSRIs are indicted for the treatment anxiety symptoms, especially when they co-occur with depression, many women may need to use a benzodiazepine for managing more severe symptoms of anxiety or insomnia. 

By |2025-06-26T08:06:04-04:00September 12th, 2024|Women's Mental Health|Comments Off on Is it Safe for Breastfeeding Mothers to Use Benzodiazepines?

Risk of Malformations in Children with Prenatal Exposure to Antidepressants and Benzodiazepines

This large cohort study from Taiwan indicates that the concomitant use of antidepressants and benzodiazepines during the first trimester is not associated with a substantial increase in risk for overall malformations.

By |2025-06-26T08:06:07-04:00August 28th, 2024|Women's Mental Health|Comments Off on Risk of Malformations in Children with Prenatal Exposure to Antidepressants and Benzodiazepines
Go to Top